CAS: 1609392-27-9
Tyk2-IN-4
CAS:1609392-27-9
Formula:
C20H19D3N8O3
Purity:
99%
Color and Shape:
Solid
Molecular weight:
425.4590
Ref: AN-AG01EO63
1g | To inquire | |
1mg | 151.00 € | |
5mg | 237.00 € | |
10mg | 560.00 € | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
Ref: 4Z-B-210001
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 23 May 2024
Deucravacitinib
CAS:1609392-27-9
Deucravacitinib (BMS-986165) inhibits IL-12/23 and type I IFN pathways[1][2]. BMS-986165 is a highly selective, orally …
Formula:
C20H19D3N8O3
Purity:
100%
Color and Shape:
Solid
Molecular weight:
425.46
Ref: TM-T14687
1mg | 69.00 € | |
5mg | 149.00 € | |
10mg | 269.00 € | |
25mg | 425.00 € | |
50mg | 625.00 € | |
100mg | 892.00 € | |
200mg | 1,205.00 € | |
500mg | 1,784.00 € | |
1ml*10 (DMSO) | 164.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Deucravacitinib
Controlled ProductCAS:1609392-27-9
Formula:
C20H19D3N8O3
Color and Shape:
Neat
Molecular weight:
425.459
Ref: TR-D665481
250mg | 9,139.00 € |
Estimated delivery in United States, on Wednesday 26 Jun 2024
BMS-986165
CAS:1609392-27-9
BMS-986165 is a P-glycoprotein (P-gp) inhibitor that has been shown to reduce the absorption of …
Formula:
C20H19D3N8O3
Purity:
Min. 95%
Molecular weight:
425.46 g/mol
Ref: 3D-JPC39227
2mg | 43.00 € | |
5mg | 69.00 € | |
10mg | 106.00 € | |
25mg | 189.00 € | |
50mg | 298.00 € |
Estimated delivery in United States, on Thursday 27 Jun 2024